Longo, J., Lutz, S., & Johnstone, C. (2013). Samarium-153-ethylene diamine tetramethylene phosphonate, a beta-emitting bone-targeted radiopharmaceutical, useful for patients with osteoblastic bone metastases. Dove Medical Press.
استشهاد بنمط شيكاغوLongo, John, Stephen Lutz, و Candice Johnstone. Samarium-153-ethylene Diamine Tetramethylene Phosphonate, a Beta-emitting Bone-targeted Radiopharmaceutical, Useful for Patients With Osteoblastic Bone Metastases. Dove Medical Press, 2013.
MLA استشهادLongo, John, Stephen Lutz, و Candice Johnstone. Samarium-153-ethylene Diamine Tetramethylene Phosphonate, a Beta-emitting Bone-targeted Radiopharmaceutical, Useful for Patients With Osteoblastic Bone Metastases. Dove Medical Press, 2013.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.